Indivior PLC $INDV Shares Bought by Public Sector Pension Investment Board

Public Sector Pension Investment Board boosted its stake in shares of Indivior PLC (NASDAQ:INDV – Free Report) by 55.5% in the 3rd quarter, HoldingsChannel reports. The fund owned 651,409 shares of the company’s stock after buying an additional 232,531 shares during the quarter. Public Sector Pension Investment Board’s holdings in Indivior were worth $23,060,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of INDV. Intech Investment Management LLC increased its stake in Indivior by 0.4% in the 3rd quarter. Intech Investment Management LLC now owns 108,262 shares of the company’s stock worth $3,881,000 after purchasing an additional 444 shares during the period. Illinois Municipal Retirement Fund lifted its position in Indivior by 1.0% in the third quarter. Illinois Municipal Retirement Fund now owns 62,933 shares of the company’s stock valued at $2,256,000 after purchasing an additional 611 shares during the last quarter. Virtus Advisers LLC lifted its position in Indivior by 24.9% in the third quarter. Virtus Advisers LLC now owns 7,871 shares of the company’s stock valued at $282,000 after purchasing an additional 1,570 shares during the last quarter. TD Waterhouse Canada Inc. bought a new stake in Indivior in the second quarter valued at approximately $63,000. Finally, GAMMA Investing LLC purchased a new stake in shares of Indivior during the second quarter valued at approximately $66,000. 60.33% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Indivior

In other Indivior news, CAO Woodrow D. Anderson bought 1,500 shares of Indivior stock in a transaction dated Thursday, August 27th. The shares were purchased at an average cost of $35.69 per share, with a total value of $53,535.00. Following the completion of the purchase, the chief accounting officer owned 27,638 shares of the company’s stock, valued at approximately $986,400.22. This represents a 5.74% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.74% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on INDV shares. Weiss Ratings cut shares of Indivior from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Wall Street Zen downgraded shares of Indivior from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 31st. Craig Hallum reiterated a “buy” rating and set a $53.00 price target on shares of Indivior in a report on Tuesday, August 4th. Barclays upped their price target on shares of Indivior from $43.00 to $45.00 and gave the company an “overweight” rating in a report on Wednesday, October 28th. Finally, Zacks Research raised shares of Indivior from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 2nd. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $46.40.

Read Our Latest Analysis on INDV

Indivior Price Performance

NASDAQ INDV opened at $28.21 on Friday. The stock has a market capitalization of $3.33 billion, a PE ratio of 7.88 and a beta of 0.84. Indivior PLC has a 1 year low of $27.68 and a 1 year high of $42.81. The business’s 50-day moving average is $33.60 and its 200 day moving average is $35.31.

Indivior (NASDAQ:INDV – Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.06 by $0.26. The business had revenue of $356.00 million during the quarter, compared to analyst estimates of $329.35 million. Indivior had a negative return on equity of 418.04% and a net margin of 32.75%. As a group, equities research analysts anticipate that Indivior PLC will post 3.66 earnings per share for the current year.

Indivior Dividend Announcement

The firm also recently disclosed a special dividend, which was paid on Friday, November 6th. Stockholders of record on Friday, October 30th were given a $8.13 dividend. The ex-dividend date was Tuesday, November 3rd.

Indivior Company Profile

(Free Report)

Indivior is a specialty pharmaceutical company focused on developing and providing treatments for substance use disorders and serious mental illness. Its products include medicines for opioid use disorder, such as Sublocade, a long-acting injectable form of buprenorphine, and Suboxone, a buprenorphine-and-naloxone treatment. The company also markets Opvee, a nasal spray used to reverse opioid overdose, and Perseris, a long-acting injectable treatment for schizophrenia. Indivior develops additional therapies through its research and development programs.

Featured Stories

Want to see what other hedge funds are holding INDV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Indivior PLC (NASDAQ:INDV – Free Report).

Institutional Ownership by Quarter for Indivior (NASDAQ:INDV)

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.